Firebrick Pharma Limited has released a press release.
Investor Update
Earlier from Firebrick Pharma
- March 2026 Quarterly Activity Report & Appendix 4C
- Firebrick Secures $1.5 million via Placement
- Trading Halt
- Registration Agreement and Approval of Nasodine in Indonesia